title: In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines.
abstract: BACKGROUND
  Targeted drug-carrying phage nanomedicines are a new class of nanomedicines that combines biological and chemical components into a modular nanometric drug delivery system. The core of the system is a filamentous phage particle that is produced in the bacterial host Escherichia coli. Target specificity is provided by a targeting moiety, usually an antibody that is displayed on the tip of the phage particle. A large drug payload is chemically conjugated to the protein coat of the phage via a chemically or genetically engineered linker that provides for controlled release of the drug after the particle homed to the target cell. Recently we have shown that targeted drug-carrying phage nanomedicines can be used to eradicate pathogenic bacteria and cultured tumor cells with great potentiation over the activity of the free untargeted drug. We have also shown that poorly water soluble drugs can be efficiently conjugated to the phage coat by applying hydrophilic aminoglycosides as branched solubility-enhancing linkers.
  
  
  RESULTS
  With an intention to move to animal experimentation of efficacy, we tested anti-bacterial drug-carrying phage nanomedicines for toxicity and immunogenicity and blood pharmacokinetics upon injection into mice. Here we show that anti-bacterial drug-carrying phage nanomedicines that carry the antibiotic chloramphenicol conjugated via an aminoglycoside linker are non-toxic to mice and are greatly reduced in immunogenicity in comparison to native phage particles or particles to which the drug is conjugated directly and are cleared from the blood more slowly in comparison to native phage particles.
  
  
  CONCLUSIONS
  Our results suggest that aminoglycosides may serve as branched solubility enhancing linkers for drug conjugation that also provide for a better safety profile of the targeted nanomedicine.
authors.affiliation: Department of Molecular Microbiology and Biotechnology, The George S, Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Israel.
authors.forename: Lilach
authors.initials: L
authors.lastname: Vaks
authors.forename: Itai
authors.initials: I
authors.lastname: Benhar
mesh_terms: D000818:Animals; D001435:Bacteriophages / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry*; D051379:Mice; D050997:Nanomedicine; D009355:Neomycin / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D004337:Drug Carriers; D009355:Neomycin